Tibet Aim Pharm Inc (002826) - Total Liabilities

Latest as of September 2025: CN¥256.63 Million CNY ≈ $37.55 Million USD

Based on the latest financial reports, Tibet Aim Pharm Inc (002826) has total liabilities worth CN¥256.63 Million CNY (≈ $37.55 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Tibet Aim Pharm Inc cash flow conversion to assess how effectively this company generates cash.

Tibet Aim Pharm Inc - Total Liabilities Trend (2013–2024)

This chart illustrates how Tibet Aim Pharm Inc's total liabilities have evolved over time, based on quarterly financial data. Check Tibet Aim Pharm Inc (002826) asset resilience to evaluate the company's liquid asset resilience ratio.

Tibet Aim Pharm Inc Competitors by Total Liabilities

The table below lists competitors of Tibet Aim Pharm Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Huaren Pharmaceutical Co Ltd SHE:300110	China	CN¥1.97 Billion
Hangzhou Seck Intelligent Tech Co SHE:300897	China	CN¥257.52 Million
C.E. Info Systems Limited NSE:MAPMYINDIA	India	Rs1.41 Billion
Ningbo Fangzheng Automobile Mould Co.Ltd. SHE:300998	China	CN¥1.53 Billion
Vietnam Construction and Import Export JSC VN:VCG	Vietnam	₫18.95 Trillion
India Tourism Development Corporation Limited NSE:ITDC	India	Rs3.68 Billion
Dare Technology Co Ltd SHE:000910	China	CN¥2.88 Billion

Liability Composition Analysis (2013–2024)

This chart breaks down Tibet Aim Pharm Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 002826 stock market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.67	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.32	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.24	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Tibet Aim Pharm Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Tibet Aim Pharm Inc (2013–2024)

The table below shows the annual total liabilities of Tibet Aim Pharm Inc from 2013 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥180.89 Million ≈ $26.47 Million	+1.81%
2023-12-31	CN¥177.68 Million ≈ $26.00 Million	-33.75%
2022-12-31	CN¥268.21 Million ≈ $39.25 Million	+157.00%
2021-12-31	CN¥104.36 Million ≈ $15.27 Million	-52.76%
2020-12-31	CN¥220.94 Million ≈ $32.33 Million	+20.58%
2019-12-31	CN¥183.24 Million ≈ $26.81 Million	+31.32%
2018-12-31	CN¥139.53 Million ≈ $20.42 Million	+8.36%
2017-12-31	CN¥128.76 Million ≈ $18.84 Million	+41.61%
2016-12-31	CN¥90.93 Million ≈ $13.31 Million	-39.16%
2015-12-31	CN¥149.44 Million ≈ $21.87 Million	+67.36%
2014-12-31	CN¥89.30 Million ≈ $13.07 Million	+9.66%
2013-12-31	CN¥81.43 Million ≈ $11.92 Million	--

About Tibet Aim Pharm Inc

SHE:002826 China Drug Manufacturers - Specialty & Generic

Market Cap

$544.09 Million

CN¥3.72 Billion CNY

Market Cap Rank

#12084 Global

#3726 in China

Share Price

CN¥19.50

Change (1 day)

-0.10%

52-Week Range

CN¥10.78 - CN¥25.74

All Time High

CN¥32.76